Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Trial of Xevinapant and Chemoradiotherapy in Adjuvant Treatment for Patients With Head and Neck Squamous Cell Carcinoma With High Risk Pathologic Features

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06084845
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:20.994146+00:00
Published At
2024-07-25T00:00:00+00:00
Record Updated At
2024-07-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Head and Neck Squamous Cell Carcinoma", "Hypopharyngeal Squamous Cell Carcinoma", "Laryngeal Squamous Cell Carcinoma", "Oral Cavity Squamous Cell Carcinoma", "Oropharyngeal Squamous Cell Carcinoma", "Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8", "Stage III Hypopharyngeal Carcinoma AJCC v8", "Stage III Laryngeal Cancer AJCC v8", "Stage III Lip and Oral Cavity Cancer AJCC v8", "Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8", "Stage IV Hypopharyngeal Carcinoma AJCC v8", "Stage IV Laryngeal Cancer AJCC v8", "Stage IV Lip and Oral Cavity Cancer AJCC v8", "Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-25"
protocolSection.identificationModule.nctId
"NCT06084845"
protocolSection.identificationModule.officialTitle
"Phase II Trial of Xevinapant and Chemoradiotherapy in Adjuvant Treatment for Patients With Head and Neck Squamous Cell Carcinoma With High Risk Pathologic Features"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Hypopharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Laryngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Oral Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.